Document is current
Any future updates will be listed below
-
Authors
Zhang, Honglei
Zhang, Cheng
Qiu, Chen
Xiang, Yukai
Jiang, Zhaoyan
Zheng, Liang
Hu, Hai
Yang, Yulong
-
Funding
Funding for this research was provided by:
Key Specialty Construction Project of Shanghai Pudong New Area Health Commission (PWZzk2022-17)
The Featured Clinical Discipline Project of Shanghai Pudong (PWYts2021-06)
Clinical Research Project of Shanghai East Hospital (DFLC2022019)
Shanghai East Hospital Key Discipline Department of Gallstone Disease (2024-DFZD-005DS)
Clinical and Mechanistic Study of Dan Ning Tablets in Improving Post-ERCP Liver Function Recovery in Patients with Common Bile Duct Stones and Obstructive Jaundice (2025HH-015)
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 25 May 2026
First Online: 29 May 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Medical Ethics Committee of East Hospital(No [2022] Review Document No. (107)), Tongji University, Shanghai, China. Therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all participants in this study (Patients under the age of 18 have obtained the informed consent of their legally responsible persons).
Consent for publication: Not Applicable.
Competing interests: The authors declare no competing interests.
